Neoadjuvant chemotherapy versus chemoradiation prior to esophagectomy: Impact on rate of complete pathologic response and survival in esophageal cancer patients

被引：0
|
作者：
Lockhart, Albert C.
Samson, Pamela Parker
Robinson, Cliff Grant
Bradley, Jeffrey D.
Puri, Varun
Broderick, Stephen R.
Patterson, G. Alexander
Meyers, Bryan F.
Crabtree, Traves
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4054
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients
    Samson, Pamela
    Robinson, Clifford
    Bradley, Jeffrey
    Lockhart, A. Craig
    Puri, Varun
    Broderick, Stephen
    Kreisel, Daniel
    Krupnick, A. Sasha
    Patterson, G. Alexander
    Meyers, Bryan
    Crabtree, Traves
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (12) : 2227 - 2237
  • [2] Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer
    Luu, Theresa D.
    Gaur, Puja
    Force, Seth D.
    Staley, Charles A.
    Mansour, Kamal A.
    Miller, Joseph I., Jr.
    Miller, Daniel L.
    ANNALS OF THORACIC SURGERY, 2008, 85 (04): : 1217 - 1224
  • [3] Complete pathologic response to neoadjuvant chemoradiation is the only predictor of survival in patients with esophageal cancer
    Meredith, K. L.
    Weber, J.
    Siegel, E.
    McLoughlin, J.
    Taruga, K.
    Shah, N.
    Melis, M.
    Kelley, S.
    Karl, R.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 26 - 26
  • [4] Complete pathologic response is independent of the timing of esophagectomy following neoadjuvant chemoradiation for esophageal cancer
    Singla, Smit
    Gabriel, Emmanuel
    Alnaji, Raed
    Du, William
    Attwood, Kristopher
    Nava, Hector
    Hochwald, Steven N.
    Kukar, Moshim
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (01) : 73 - 79
  • [5] Complete Pathologic Response is Independent of the Timing of Esophagectomy and is Predictive of Improved Survival following Neoadjuvant Chemoradiation for Esophageal Cancer
    Singla, S.
    Kukar, M.
    Alnaji, R. M.
    Du, W.
    Attwood, K.
    Nava, H.
    Nurkin, S. J.
    Kuvshinoff, B. W.
    Hochwald, S.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S14 - S14
  • [6] Impact of neoadjuvant chemoradiation on pathologic response and survival of patients with rectal cancer
    Elkased, Ahmed F.
    Asaad, Nancy Y.
    Abd Al-Bary, Naser M.
    Amar, Mohamed S.
    Elgezawy, Mohamed B.
    EGYPTIAN JOURNAL OF SURGERY, 2019, 38 (01): : 155 - 159
  • [7] Pathologic complete response among patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A meta-analysis.
    Gaber, Charles
    Sarker, Jyotirmoy
    Abdelaziz, Abdullah
    Okpara, Ebere
    Lee, Todd
    Klempner, Samuel J.
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 305 - 305
  • [8] Nomogram Score of Pathologic Complete Response to Neoadjuvant Chemoradiation Predicts for Survival Outcomes in Esophageal Cancer Patients Treated With Definitive Chemoradiation
    Wang, J.
    Lin, S. H.
    Allen, P. K.
    Juloori, A.
    Lee, J. K.
    Komaki, R.
    Liao, Z.
    Swisher, S. G.
    Hofstetter, W. L.
    Ajani, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S86 - S87
  • [9] Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer
    Haisley, Kelly R.
    Laird, Amy E.
    Nabavizadeh, Nima
    Gatter, Ken M.
    Holland, John M.
    Vaccaro, Gina M.
    Thomas, Charles R., Jr.
    Schipper, Paul H.
    Hunter, John G.
    Dolan, James P.
    JAMA SURGERY, 2016, 151 (11)
  • [10] The Survival Impact of Neoadjuvant Chemoradiation versus Chemotherapy on Gastric Cancer Patients
    Baker, Matthew
    Azab, Basem
    Andrawes, Sherif
    Abeysekera, Aravinda
    Patel, Hardik
    Butler, Kevin S.
    Younan, Duraid
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 502 - 502
12345